OutcomesAI, a healthcare company building a new model of scalable nursing, announced $10 million in seed financing led by Santé Ventures. OutcomesAI combines AI voice agents with licensed nurses to extend nursing capacity, reduce costs, and give patients faster access to care. The funding will accelerate expansion into health systems, virtual care programs, and pharmaceutical partnerships.
Nurses spend most of their time on triage, follow-ups, and care coordination, with only a third of each shift devoted to direct patient care. Nearly half are considering leaving the workforce, even as demand surges: specialty care wait times exceed 30 days, and virtual programs face a 10x increase in patient messages. With a projected global shortfall of 13 million nurses by 2030, health systems are forced to staff costly nursing resources, driving up costs, straining programs, and leaving patients waiting too long for care.
OutcomesAI addresses this crisis with Glia, its AI engine purpose-built for nursing. Glia combines AI voice agents that manage inbound and outbound patient calls with licensed OutcomesAI nurses delivering services like triage, virtual care, post-acute follow-up, and patient support programs. Voice agents capture symptoms, schedule visits, coordinate follow-ups, and provide education — all in multiple languages — while nurses are supported by AI productivity tools like real-time scribing and protocol guidance. This hybrid model creates 3–5× more nursing capacity, reduces costs by 40–50% compared to outsourced nurse triage, and consistently improves patient experience.
Health Technology Insights: Doctivity Health Launches Doctivity AI for Healthcare Growth
“Healthcare is running out of nursing capacity, and incremental fixes won’t solve it,” said Kuldeep Singh Rajput, Founder and CEO of OutcomesAI. “With OutcomesAI, we’re not replacing nurses — we’re multiplying them. By combining AI voice agents with licensed nursing teams, we give back time to the people at the center of care, reduce burnout, and build a sustainable, scalable model for the future.”
“With a projected shortfall of 13 million nurses by 2030, the industry is desperate for scalable solutions,” said Joe Cunningham, M.D., Founding Managing Director, Santé Ventures. “We invested in OutcomesAI because they are rethinking how nursing capacity can be scaled — not with incremental fixes, but with a model that blends AI with clinical services to deliver measurable impact. We believe this approach has the potential to redefine virtual care and set a new standard for safety, empathy, and efficiency in healthcare.”
Health Technology Insights: DataJoint Raises $4.9 Million to Transform Data Management in Science
The new funding will accelerate OutcomesAI’s commercial rollout, launch of dedicated nursing service lines, and scaling of enterprise partnerships across health systems, virtual care providers, and pharma. In 2024, the company launched the OutcomesAI Collaboratory, bringing together five leading health systems and virtual care companies to validate Glia’s safety, accuracy, and clinical performance. Building on these results, OutcomesAI will publish real-world case studies demonstrating measurable ROI — including early findings where Glia reduced nurse workload by hundreds of hours per month while doubling patient-to-nurse ratios.
The OutcomesAI leadership team combines deep experience in healthcare, AI, and commercialization, including executives from Mayo Clinic, Amwell, Philips, Best Buy Health, and Biofourmis. Rajput, who previously founded Biofourmis, brings proven expertise in building category-defining companies at the intersection of clinical care and technology.
As part of the financing, Joe Cunningham, M.D., Founding Managing Director of Santé Ventures; Linda Finkel, Senior Advisor, AVIA; Dennis McWilliams, Managing Director at Santé Ventures; and Kevin White, Ph.D., Co-founder of Tempus AI, will join the Board of Directors, alongside Founder and CEO Kuldeep Singh Rajput.
Health Technology Insights: ENHERTU Gets FDA Nod for High-Risk Early HER2+ Breast Cancer
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – businesswire
